Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Metro Healthcare Indonesia Tbk. (CARE) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Metro Healthcare Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Metro Healthcare Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.16T, 119.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 86× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Metro Healthcare Indonesia Tbk. is more actively traded (119.3K versus 62.5K). Which is the better fit depends on your goals.

CAREOBAT
Market Cap
14.16T164.65B
Volume
119.3K62.5K
Lot
1.19K625
Turnover
50.51M15.03M
Average Price
423.41240.55
Value
50.51M15.03M
Indicative Equilibrium Price
426238
Indicative Equilibrium Volume
50100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CARE
View details
OBAT
View details

About Metro Healthcare Indonesia Tbk.

PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .

Read more on CARE

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT